POLYSAN pharmaceutical plant has modern production facilities in full compliance with international, European and Russian standards of GMP (Good Manufacturing Practice). In June 2005 the first stage of the plant was put in operation, the total area 4,900 sq.m with non-sterile production (tablets and liniments) and sterile production (injection and infusion forms). The second stage of the plant was opened in June 2012. New production facility area is 5,778 sq.m, it increased the plant production capacity up to 12 million units of infusion products per year. The total clean room area is 2,600 sq.m.
The plant equipment is sourced from the best of European suppliers - Bosch, Fette, Marchesini, Plümat, Bausch + Ströbel, GEA, Fedegari, IMA, Stilmas. It meets all the modern production requirements: higher level of automation, reliability, safety, product quality guarantee, serviceability and maintainability.
POLYSAN manufacturing facilities are in full compliance with international environmental standards. The integrated environment management system is implemented and certified according to ISO 14001:2004. Currently 450 employees work at the pharmaceutical plant. All of them are highly qualified professionals. The company’s staff training system includes professional training, industrial safety, occupational health and safety, product quality assurance and environment protection compliance, such training system sets out high requirements to each employee of the pharmaceutical plant.
Modern waste treatment facilities are put into operation as a part of the 2nd stage of the plant development.
All production processes are automated. The human factor is minimized with the use of industrial automation. In 2014 POLYSAN received a gold medal in 100 Best Russian Enterprises awards. Ecology and Environment Management”. This is a recognition of the company’s achievement in the environment protection and safety.
POLYSAN pharmaceutical plant